CMPX Dividend History & Analysis | N/A Yield
CMPX has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Biotechnology
| Symbol | Market Cap USD | Dividend Yield TTM | Yield on Cost 5y |
|---|---|---|---|
| ABBV | 403,830 M | 3.70% | 9.24% |
| AMGN | 176,250 M | 3.65% | 5.93% |
| GILD | 150,882 M | 2.62% | 6.13% |
| HLN | 44,530 M | 1.75% | 2.46% |
| BIM | 15,096 M | 0.79% | 0.81% |
| Symbol | Market Cap USD | Growth Rate (CAGR) | Payout Consistency |
|---|---|---|---|
| BTX | 1,406 M | 134% | 95.6% |
| HLN | 44,530 M | 30.1% | 100% |
| AMGN | 176,250 M | 7.84% | 100% |
| BIM | 15,096 M | 9.76% | 96.0% |
| ABBV | 403,830 M | 5.98% | 100% |
Quality Dividend Peers in Biotechnology
3.65% Yield
2.62% Yield
CMPX Dividend History: as of January 2026
No dividends paid yet.CMPX Dividend FAQ
Compass Therapeutics (NASDAQ:CMPX) is a Boston-based, clinical-stage biotech that concentrates on antibody-based oncology therapies. Its lead candidates are tove-cimig, a DLL4/VEGF-A bispecific designed to shut down tumor angiogenesis; CTX-471, an IgG4 agonist of the T-cell co-stimulatory receptor CD137; and CTX-8371, a PD-1/PD-L1 bispecific checkpoint inhibitor. The company also maintains a broader pipeline of bispecifics targeting VEGF-A, PD-1 and other immune-modulatory pathways.
What is the Dividend Yield of CMPX?
As of January 2026, CMPX`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 5.17.Does CMPX pay a dividend?
As of January 2026 CMPX does not pay a dividend.How often does CMPX pay dividends?
Over the last 12 months, CMPX has issued dividend payments.CMPX dividend forecast
Based on historical data, the forecasted dividends per share for CMPX for the next 4 payments are between 0 (+0.0%) and 0 (+0.0%).This suggests the dividend will remain relatively stable.
Will CMPX pay dividends in 2026?
The next Ex-Dividend date for Compass Therapeutics (CMPX) is currently unknown.What is the next Ex-Dividend Date for CMPX?
The next Ex-Dividend date for Compass Therapeutics (CMPX) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of CMPX?
CMPX's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of CMPX?
CMPX's 5-Year Yield on Cost is -%. If you bought CMPX's shares at 8.50 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of CMPX?
CMPX Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does CMPX have a good Dividend Yield?
CMPX`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of CMPX?
The Dividend Payout Ratio of CMPX is unknown.What is the Dividend Rating of CMPX?
CMPX`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield
- Annual dividend per share divided by current share price.
- Payout Ratio
- Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
- Payout FCF
- Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
- Growth Rate (CAGR)
- Compound annual growth rate of dividends over the last 5 years.
- Consistency
- Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
- Yield on Cost
- Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
- Streak
- Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
- Dividend Rating
- Proprietary score (0-100) combining yield, growth, safety and consistency.
Last update: 2026-01-05 02:15